Structure-based Drug Design Targeting Biosynthesis of Isoprenoids: A Crystallographic State of the Art of the Involved Enzymes

Publisher： Bentham Science Publishers

E-ISSN： 1875-5550|9|2|117-137

ISSN： 1389-2037

Source： Current Protein and Peptide Science, Vol.9, Iss.2, 2008-04, pp. : 117-137

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Based Drug Design: Docking and Scoring

By  

Current Protein and Peptide Science, Vol. 8, Iss. 4, 2007-08 ,pp. : 312-328

Bentham Science Publishers

Access to resources Recommend Favorite

Crystal engineering of HIV-1 reverse transcriptase for structure-based drug design

By Bauman Joseph D.  

Nucleic Acids Research, Vol. 36, Iss. 15, 2008-09 ,pp. : 5083-5092

Oxford University Press

Access to resources Recommend Favorite

Development of a Protease Production Platform for Structure-Based Drug Design

By  

Current Protein and Peptide Science, Vol. 8, Iss. 5, 2007-10 ,pp. : 439-445

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis. Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes

By  

Current Enzyme Inhibition, Vol. 7, Iss. 2, 2011-07 ,pp. : 79-95

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based and ligand-based drug design for microsomal prostaglandin E synthase-1 inhibitors

By Li Chia-Ling   Chang Tung-Ti   Sun Mao-Feng   Chen Hsin-Yi   Tsai Fuu-Jen   Fisher Mark   Chen Calvin Yu-Chian   Lee Chun-Lin   Fang Wen-Chang   Wong Yung-Hao  

Molecular Simulation, Vol. 37, Iss. 3, 2011-03 ,pp. : 226-236

Taylor & Francis Ltd

Access to resources Recommend Favorite